U.S., March 18 -- ClinicalTrials.gov registry received information related to the study (NCT06878729) titled 'Antegrade Dissection and Re-entry Versus Retrograde Strategy in CTO PCI' on March 04.
Brief Summary: The ADRENALINE trial has been designed as a multi-center, prospective randomized study to compare the procedural and periprocedural outcomes of coronary chronic total occlusion (CTO) percutaneous coronary intervention (PCI) using antegrade dissection and re-entry (ADR) versus retrograde strategy. Beyond the patient-oriented outcomes, the influence of the studied CTO PCI strategies on the stress levels among interventional cardiologists will be explored.
The main questions it aims to answer are as follows:
* What is the difference ...